Norsk Titanium AS
Norsk Titanium AS (NORSF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Norsk Titanium AS (NORSF), covering cash flow, earnings, and balance sheets.
Norsk Titanium AS (NORSF) Income Statement & Financial Overview
Analyze Norsk Titanium AS’s NORSF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $3.07M | $1.26M | $1.37M | $655000.00 |
| Cost of Revenue | $13.08M | $3.34M | $11.52M | $1.35M |
| Gross Profit | -$10.010M | -$2.08M | -$10.14M | -$690500.00 |
| Gross Profit Ratio | -$3.26 | -$1.65 | -$7.40 | -$1.05 |
| R&D Expenses | $0.00 | $0.00 | $2.04M | $2.04M |
| SG&A Expenses | $3.41M | $7.30M | $2.90M | $3.23M |
| Operating Expenses | $3.41M | $10.87M | $2.90M | $10.06M |
| Total Costs & Expenses | -$16.49M | $14.21M | $14.42M | $11.40M |
| Interest Income | $399819.00 | $348522.00 | $38714.00 | $8500.00 |
| Interest Expense | $0.00 | $42.11M | $362034.00 | $0.00 |
| Depreciation & Amortization | $818723.00 | $891000.00 | $961589.00 | $247833.00 |
| EBITDA | $6.56M | -$12.12M | -$21.15M | -$5.98M |
| EBITDA Ratio | $2.14 | -$9.61 | -$8.81 | -$9.14 |
| Operating Income | -$13.42M | -$12.95M | -$13.04M | -$6.23M |
| Operating Income Ratio | -$4.37 | -$10.27 | -$9.51 | -$9.52 |
| Other Income/Expenses (Net) | $19.16M | -$14.04M | -$9.43M | -$4.55M |
| Income Before Tax | $5.74M | -$26.98M | -$22.47M | -$10.74M |
| Income Before Tax Ratio | $1.87 | -$21.40 | -$16.38 | -$16.40 |
| Income Tax Expense | $0.00 | $2.00 | -$15695.00 | $7500.00 |
| Net Income | $5.74M | -$26.98M | -$22.46M | -$10.73M |
| Net Income Ratio | $1.87 | -$21.40 | -$16.37 | -$16.38 |
| EPS | $0.01 | -$0.06 | -$0.06 | -$0.04 |
| Diluted EPS | $0.01 | -$0.06 | -$0.06 | -$0.04 |
| Weighted Avg Shares Outstanding | $502.80M | $477.52M | $394.31M | $269.97M |
| Weighted Avg Shares Outstanding (Diluted) | $502.80M | $477.52M | $394.31M | $269.97M |
The company's financials show resilient growth, with revenue advancing from $655000.00 in Q3 2023 to $3.07M in Q4 2024. Gross profit remained healthy with margins at -326% in Q4 2024 compared to -105% in Q3 2023. Operating income hit -$13.42M last quarter, sustaining a consistent -437% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $6.56M. Net income rose to $5.74M, while earnings per share reached $0.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan